What is the difference between Japan's precision cancer checkup and China's?

Last year I took my father to Japan for a medical checkup, and at that time I made an appointment with a medical checkup organization on behalf of my father through Hussain Kangyun. During our medical checkup in Japan, the medical interpreter talked to us about the differences in medical checkups. There were a lot of things that we didn't even know before we went to Japan for the medical checkup. Let me briefly tell you about them.

First, the differences in the medical checkup itself.

Japan's cancer prevention medical checkups have been built up over 30 years, forming a whole set of multi-level screening system. While the domestic physical examination is mostly a single examination, which can not form a systematic cancer screening. You should know that there are more than 300 kinds of known cancers, and it is a very systematic project to screen these cancers clearly, and the country is still very insufficient in this regard.

Then there is a difference in equipment. In fact, the equipment of individual medical checkup structures in the first-tier cities in China is already very advanced, but the per capita ownership of the equipment is still far lower than that of developed countries like Japan. In fact, Japan has more per capita ownership of most medical equipment than the United States.

And the domestic medical examination of the doctor are general medical personnel, in addition to their own responsible for the examination of the data outside the project is not very sensitive. Japan is more than 10 years of professional doctors, and is a multi-specialty team work, the physical examination data has a strong sensitivity, through a variety of physical examination data to comprehensively determine the cancer situation. This is also a big difference.

Then we talk about the difference in results:

1. Currently, more than 70% of cancers in China are found in the middle and late stages; more than 80% of cancers in Japan are found in the early stages.

2. The inability to obtain early detection results in a much lower 5-year survival rate for cancer patients in China than in Japan.